NPWBP (Neuropeptide W/B Signal Peptide-Interacting Protein) is implicated in the modulation of neuropeptide signaling pathways that play crucial roles in regulating a variety of physiological functions, including stress response, energy balance, appetite, and pain perception. This protein interacts with the signal peptides of neuropeptides W and B, which are known to influence a wide array of central nervous system activities. The precise functions of NPWBP, while not fully elucidated, suggest its involvement in the proper processing and regulation of these neuropeptides, ensuring that their signaling is executed correctly and efficiently. By stabilizing or facilitating the proper folding and maturation of neuropeptides, NPWBP contributes to the maintenance of normal physiological processes that are vital for overall health and homeostasis.
The inhibition of NPWBP can lead to significant disruptions in neuropeptide function, potentially impacting the neurological and systemic processes they regulate. One mechanism of NPWBP inhibition could involve the direct interaction of inhibitory molecules that bind to NPWBP, preventing it from interacting effectively with its target neuropeptides. This inhibition could interfere with the stability or processing of the neuropeptides, affecting their maturation and release into the neuronal synapse. Another potential mechanism for inhibiting NPWBP involves alterations in gene expression. Transcriptional repression or modifications in the promoter region of the NPWBP gene could lead to decreased production of the protein, subsequently reducing its regulatory influence on neuropeptide signaling pathways. Moreover, post-translational modifications such as phosphorylation, acetylation, or ubiquitination could alter the structural integrity or functional capacity of NPWBP, further hindering its role in neuropeptide modulation. Understanding these inhibitory processes is essential for comprehending how NPWBP influences neuropeptide signaling and the potential consequences of its dysregulation in related neurological and physiological disorders.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
Can inhibit the splicing mechanism by binding to the spliceosome, indirectly affecting NPWBP's role in mRNA splicing. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Inhibits SF3B complex within the spliceosome, thus potentially affecting proteins like NPWBP involved in mRNA processing. | ||||||
Herboxidiene | 142861-00-5 | sc-506378 | 1 mg | $1009.00 | ||
Binds to the spliceosome and disrupts its function, which can indirectly inhibit NPWBP. | ||||||
FR901464 | 146478-72-0 | sc-507352 | 5 mg | $1800.00 | ||
Binds to the spliceosome, potentially affecting NPWBP's role in mRNA splicing. | ||||||
Chlorhexidine | 55-56-1 | sc-252568 | 5 g | $103.00 | 3 | |
As an antiseptic, it can interfere with cell membrane permeability, potentially affecting nuclear proteins. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Binds to DNA and inhibits transcription, which might indirectly affect NPWBP's role in mRNA processing. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with the transcription process, which could indirectly modulate NPWBP function. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA polymerase II, affecting mRNA synthesis and potentially NPWBP's function. | ||||||